Reversal of Atrial Substrate to Prevent Atrial Fibrillation Pilot Study

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

November 30, 2019

Conditions
Atrial Fibrillation
Interventions
BEHAVIORAL

Aggressive Risk Factor Control

"1.) Sleep apnea screening, therapy is recommended if apopnea-hypopnea (AHI) index is greater than 15, with a target index of less than 5.~2\) Counseling regarding alcohol reduction to 2 drinks/day for men, 1 drink/day for women, no binge drinking (\>5 drinks at one setting).~3\) Participation in a 12 week structured, home-based exercise program and nutritional counseling. Weight reduction will be emphasized through modification of diet and exercise.~4\) An OMRON BP monitor will be supplied to each patient. A target SBP of \<140/80 mm/Hg will be targeted.~5\) Smoking cessation - through local resources already established at each site 6) Management of diabetes to achieve HgA1c\<6.5%"

OTHER

Standard of Care

Recommendations based on current guidelines

Trial Locations (1)

B3H 3A7

QE II Health Sciences Centre, Halifax

All Listed Sponsors
collaborator

Canadian Cardiovascular Society

OTHER

lead

Nova Scotia Health Authority

OTHER

NCT03186976 - Reversal of Atrial Substrate to Prevent Atrial Fibrillation Pilot Study | Biotech Hunter | Biotech Hunter